These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32790416)

  • 1. Influence of Drug-Silica Electrostatic Interactions on Drug Release from Mesoporous Silica-Based Oral Delivery Systems.
    Hate SS; Reutzel-Edens SM; Taylor LS
    Mol Pharm; 2020 Sep; 17(9):3435-3446. PubMed ID: 32790416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of Adsorption, Supersaturation and the Presence of an Absorptive Sink on Drug Release from Mesoporous Silica-Based Formulations.
    Hate SS; Reutzel-Edens SM; Taylor LS
    Pharm Res; 2020 Aug; 37(8):163. PubMed ID: 32754797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supersaturation Potential of Ordered Mesoporous Silica Delivery Systems. Part 1: Dissolution Performance and Drug Membrane Transport Rates.
    Dening TJ; Taylor LS
    Mol Pharm; 2018 Aug; 15(8):3489-3501. PubMed ID: 29985627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of an adsorption isotherm to explain incomplete drug release from ordered mesoporous silica materials under supersaturating conditions.
    Dening TJ; Zemlyanov D; Taylor LS
    J Control Release; 2019 Aug; 307():186-199. PubMed ID: 31247279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous silica formulation strategies for drug dissolution enhancement: a review.
    McCarthy CA; Ahern RJ; Dontireddy R; Ryan KB; Crean AM
    Expert Opin Drug Deliv; 2016; 13(1):93-108. PubMed ID: 26549623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
    Pattnaik S; Pathak K
    Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
    Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
    J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Drug Adsorption onto the Silica Surface in Drug Release from Mesoporous Silica Systems.
    McCarthy CA; Ahern RJ; Devine KJ; Crean AM
    Mol Pharm; 2018 Jan; 15(1):141-149. PubMed ID: 29219325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
    Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
    Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of solid SEDDS, VII: Effect of pore size of silica on drug release from adsorbed self-emulsifying lipid-based formulations.
    Gumaste SG; Serajuddin ATM
    Eur J Pharm Sci; 2017 Dec; 110():134-147. PubMed ID: 28506870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing oral bioavailability of poorly soluble drugs with mesoporous silica based systems: opportunities and challenges.
    Bremmell KE; Prestidge CA
    Drug Dev Ind Pharm; 2019 Mar; 45(3):349-358. PubMed ID: 30411991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation.
    McCarthy CA; Faisal W; O'Shea JP; Murphy C; Ahern RJ; Ryan KB; Griffin BT; Crean AM
    J Control Release; 2017 Mar; 250():86-95. PubMed ID: 28132935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoporous silica particles as potential carriers for protein drug delivery: protein immobilization and the effect of displacer on γ-globulin release.
    Ajiboye AL; Trivedi V; Mitchell J
    Drug Dev Ind Pharm; 2020 Apr; 46(4):576-586. PubMed ID: 32162557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards establishing structure-activity relationships for mesoporous silica in drug delivery applications.
    Rosenholm JM; Lindén M
    J Control Release; 2008 Jun; 128(2):157-64. PubMed ID: 18439699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of ordered mesoporous silica for oral delivery of poorly soluble drugs.
    Vialpando M; Martens JA; Van den Mooter G
    Ther Deliv; 2011 Aug; 2(8):1079-91. PubMed ID: 22833866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant properties of probucol released from mesoporous silica.
    Lau M; Giri K; Garcia-Bennett AE
    Eur J Pharm Sci; 2019 Oct; 138():105038. PubMed ID: 31398394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.